Biogen Inc. discovers, develops, and delivers therapies for neurological diseases.
Explore more US and African stocks, read the latest market news, or compare African stock exchanges on Wallflake.
Biogen Inc. discovers, develops, and delivers therapies for neurological diseases. Biogen Inc. operates in the Healthcare sector and trades on the NASDAQ under the ticker BIIB.
Biogen Inc. is listed on the NASDAQ, where it trades under the ticker symbol BIIB. It is classified in the Healthcare sector.
BIIB last traded at USD 220.81 on 4 September 2026, down 1.65% on the session. Live prices for Biogen Inc. update through the trading day on Wallflake.
Biogen Inc. has a market capitalisation of approximately USD 32.63B, based on its closing price on 4 September 2026.
Over the past 52 weeks BIIB has traded between a low of USD 135.39 and a high of USD 225.80.
BIIB has a price-to-earnings (P/E) ratio of 25.08 and earnings per share (EPS) of USD 8.79. These figures are reported metrics, not a valuation opinion — Wallflake does not issue buy, sell or hold recommendations.
BIIB shares are bought and sold through a broker licensed to trade on the NASDAQ. You open an account with a licensed broker, fund it, and place an order quoting the ticker BIIB. Wallflake is a market-data and research platform, not a broker, and does not execute trades or give investment advice. See our NASDAQ guide for how the market works. Read the guide
Figures are drawn from Wallflake's market data and are provided for information only. Nothing here is investment advice or a recommendation to buy or sell any security.